THE WELCH COMPANY
440 Davis Court #1602
San Francisco, CA 94111-2496
415 781 5700
rodwelch@pacbell.net
S U M M A R Y
DIARY: February 18, 2007 04:59 PM Sunday;
Rod Welch
Millie begins taking Keflex to relieve symptoms cellulitus left arm.
1...Summary/Objective
2...Case Study Exercise Strengthens Immune System Risks Heart Disorder
..............
Click here to comment!
CONTACTS
SUBJECTS
Cellulitis Treatment Antibiotic Keflex Millie Begins Taking Medicati
1703 -
1703 - ..
1704 - Summary/Objective
1705 -
170501 - Follow up ref SDS 39 0000.
170502 -
170503 -
170504 -
170505 -
170507 - ..
1706 -
1707 -
1708 - Progress
1709 -
170901 - About noon today, Millie played tennis again for the second day in a
170902 - row. This is the first time Mil has played tennis in about 10 years.
170903 - Millie went to exercise class this morning, following up exercise
170904 - class for two days a week ago. ref SDS 39 HF5H
170905 -
170906 - [On 070222 Brigid investigated effects of tennis on lymphedema and
170907 - cellulitis in left arm, and determined that playing right handed
170908 - makes this a manageable risk for restoring fitness to strengthen
170909 - the immune system. ref SDS 41 457F
170911 - ..
170912 - Former shortness of breath and continual weakness seems less, and
170913 - energy seems higher. May signal side effects of chemotherapy with
170914 - Taxotere and capecitabine (Xeloda) that ended on 061201, ref SDS 32
170915 - 0001, have brought greater vigor that enables exercise to regain
170916 - fitness, cited by the doctor on 050729, ref SDS 19 XX7G, and which in
170917 - turn strengthens the immune system that helps resist cancer, and side
170918 - effects of chemotherapy, discussed by the doctor on 030606.
170919 - ref SDS 3 JP7G
170921 - ..
170922 - Today, Millie wore a watch that, also, monitors her heart beat. While
170923 - playing and chasing balls, the monitor sounded several alerts that
170924 - Millie's pulse exceeded 138. The high was about 164, which startled
170925 - Millie.
170927 - ..
170928 - We hit balls for about 45 minutes, and did not play a match.
170930 - ..
170931 - Millie commented that tennis today seemed significantly more
170932 - strenuous than aerobics class at the gym. Her face was flushed, and
170933 - she breathed heavily.
170935 - ..
170936 - During a meeting at Kaiser on 070105, Millie asked about referral to a
170937 - heart specialist for review of CT test on 060930 that reported
170938 - findings of enlarged right ventricle. ref SDS 36 CV5L Research on
170939 - 061012 described a heart disorder Cor Pulmonale. ref SDS 29 IM5J
170940 - Millie therefore asked for clearance on 070105 to resume exercising in
170941 - order to restore fitness that strengthens the immune system.
170942 - ref SDS 36 MA9K At that time, the doctor said Millie can resume
170943 - working out, and to be careful. ref SDS 36 G35K
170945 - ..
170946 - After playing tennis, Millie noticed her left arm still seems swollen
170947 - and slightly inflammed, cited by the primary care physician during
170948 - examination on 070202. ref SDS 38 JP6F
170949 -
170950 - [On 070222 Brigid verified that Millie plays tennis right
170951 - handed; which avoids trauma to left arm that is sensitive to
170952 - activity resulting in complications of cellulitis from
170953 - lymphedema. ref SDS 41 IS5K
170955 - ..
170956 - Therefore, Millie began taking Keflix pills for cellulitis, which she
170957 - picked up from the Kaiser Pharmacy, reported in her letter to Kaiser
170958 - on 070217. ref SDS 40 9C6J
170959 -
170960 - [On 070222 examination at UCSF indicates rash on upper left arm
170961 - likely expanding IBC. ref SDS 41 B64F
170963 - ..
170964 - [On 070330 Cellulitis diagnosed during meeting at Kaiser,
170965 - ref SDS 43 7C7F, but subsided quickly, and so no medication was
170966 - taken. ref SDS 43 N75M
170968 - ..
170969 - [On 070607 recurrent cellulitis diagnosed during examination at
170970 - UCSF for treatment of IBC with cetuximab, ref SDS 45 8H3I;
170971 - condition worsened during treatment in the Infusion Clinic,
170972 - temperature over 102, ref SDS 45 8J37; UCSF treated Millie with
170973 - ceftriaxone antibiotics, ref SDS 45 8J9R, cellulitis seemed to
170974 - subside, and temperature dropped to 101.4, UCSF released Millie
170975 - to go home, ref SDS 45 8J5C; Kaiser prescribed outpatient
170976 - ceftriaxone antibiotics for 5 days. ref SDS 45 8L46
170977 -
170978 -
170979 -
1710 -
SUBJECTS
Case Study Exercise Strengthens Immune System Resists Cancer Increas
2803 -
280401 - ..
280402 - ..
280403 - Case Study Exercise Strengthens Immune System Risks Heart Disorder
280404 -
280405 - Follow up ref SDS 35 JU9L.
280406 -
280407 - On 070105 Millie asked about referral for meeting with heart
280408 - specialist to get clearance to resume exercise. This presents an
280409 - issue to balance fitness to strengthen immune system that helps resist
280410 - cancer, and accomodate aggressive chemotherapy treatment, against
280411 - risks of heart disorder that may cause an immediate terminal event.
280412 -
280413 - 1. Millie had a left breast lumpectomy and
280414 - lymph node removal left axilla on 020312,
280415 - ref SDS 1 0001, with reexcision on 020329,
280416 - ref SDS 2 0001, she she then had 2 treatments
280417 - with AC and was switched to Taxotere for
280418 - 6 treatments, ending in December 2002.
280419 - She had no treatment during 2003; cancer
280420 - marker continued to rise in 2003 and lumps
280421 - under left axilla raised concerns. Millie
280422 - met every few months with the doctor during
280423 - 2003, and asked about resuming treatment.
280425 - ..
280426 - 2. Exercise for fitness important for
280427 - maintaining immune system that resists
280428 - cancer and side effects of chemotherapy
280429 - which can prevent treatment of
280430 - cancer................................ 030606, ref SDS 3 JP7G
280432 - ..
280433 - 3. Chemotherapy side effects of fatigue,
280434 - weakness, reduction of immune system,
280435 - feeling lousy that reduce exercise
280436 - causing loss of fitness that further
280437 - weakens immune system, and causes
280438 - shortness of breath, heavy
280439 - chest................................. 030606, ref SDS 3 O44J
280441 - ..
280442 - 4. Millie has fitness level of a 50 year
280443 - old and so can accomodate aggressive
280444 - chemotherapy treatment................ 030606, ref SDS 3 NE57
280446 - ..
280447 - 5. Doctor cites Millie's fitness aids
280448 - treatment prospects................... 030710, ref SDS 4 FZ4N
280450 - ..
280451 - 6. Patient's habits of regular exercise
280452 - and diet maintain health and fitness
280453 - help avoid advance of
280454 - disease............................... 031205, ref SDS 5 GW8F
280456 - ..
280457 - 7. Treatment begins cancer recurrence
280458 - diagnosed IBC; patient placed in drug
280459 - trial Taxol and bevacizumab
280460 - (Avastin)............................. 040420, ref SDS 6 W55O
280462 - ..
280463 - 8. Fatigue, shortness of breath, heavy
280464 - chest, cough side effects chemotherapy
280465 - clinical study Taxol bevacizumab
280466 - (Avastin) drug
280467 - trial................................. 040517, ref SDS 7 RZ4I
280469 - ..
280470 - 9. Fatigue, shortness of breath, heavy
280471 - chest, chronic cough side effects
280472 - increase, cough medicine
280473 - prescribed............................ 040614, ref SDS 8 RZ4I
280475 - ..
280476 - 10. Patient's good health, strength, lifestyle
280477 - of exercise help recover from cancer
280478 - treatments giving doctor flexibility
280479 - allowing chemotherpay when blood
280480 - counts do not meet standing
280481 - guidelines............................ 040614, ref SDS 8 6T7F
280483 - ..
280484 - 11. Fatigue, shortness of breath, heavy
280485 - chest, chronic cough increase; Genentec,
280486 - manufacturer of Avastin makes public
280487 - announcement increased risk for pulminary
280488 - embolism (blood clots); Millie reports
280489 - family history of blood clot issues,
280490 - and asks about rising symptoms of
280491 - coughing, difficult breathing, heaviness
280492 - in chest; doctor advises increased risk
280493 - on Avastin trial related to personal
280494 - history of blood clots, rather than
280495 - family history; no change in treatment
280496 - prescribed............................ 040812, ref SDS 10 RZ4I
280498 - ..
280499 - 12. Fatigue, shortness of breath, heavy
280500 - chest increase; cough medicine redeuces
280501 - sore throat from chronic cough; doctor
280502 - advises CT tests do not show cause
280503 - of problems........................... 040909, ref SDS 11 RZ4I
280505 - ..
280506 - 13. 2nd opinion on rising fatigue, shortness
280507 - of breath, heavy chest, chronic cough
280508 - Doctor Benz at UCSF suggests Kaiser
280509 - investigate lung
280510 - cancer................................ 041018, ref SDS 12 LX96
280512 - ..
280513 - 14. Fatigue, shortness of breath, heavy
280514 - chest increase; pulmonary embolism side
280515 - effect bevacizumab (Avastin) diagnosed
280516 - CT test; Millie removed clinical study
280517 - Taxol and bevacizumab (Avastin); begins
280518 - treatment for pulmonary
280519 - embolims with Coumadin
280520 - (warfarin)............................ 041104, ref SDS 13 RZ4I
280522 - ..
280523 - 15. Energy restored, cough ends after ending
280524 - treatment with bevacizumab (Avastin), and
280525 - getting treatment for pulmonary embolism
280526 - CT test reports no visualization
280527 - of former pulmonary embolism after
280528 - treatment with Coumadin
280529 - (warfarin)............................ 041230, ref SDS 14 RZ4I
280531 - ..
280532 - 16. Chemotherapy begins AC................ 050104, ref SDS 15 0001
280534 - ..
280535 - 17. Chemotherapy switched to Taxotere
280536 - and capecitabine
280537 - (Xeloda).............................. 050415, ref SDS 16 407N
280539 - ..
280540 - 18. Chemotherapy side effects difficult to
280541 - tolerate, patient would rather be dead
280542 - than continue; dose
280543 - reduced............................... 050516, ref SDS 17 AQ6G
280545 - ..
280546 - 19. Article reports study found exercise
280547 - repairs some of the cumulative damage
280548 - chemotherapy causes to the immune
280549 - system; this prolongs effectiveness of
280550 - chemotherapy treatment to aid
280551 - recovery from breast
280552 - cancer................................ 050609, ref SDS 18 F88M
280554 - ..
280555 - 20. Quality of life from strength and range
280556 - of motion are obvious benefits of
280557 - exercise.............................. 050609, ref SDS 18 F93X
280559 - ..
280560 - 21. Side effects escalate, very difficult
280561 - to tolerate even with 25% reduced dose,
280562 - doctor maintains strength of capecitabine
280563 - (Xeldoa) for two (2) more treatments
280564 - to guard against another
280565 - relapse............................... 050729, ref SDS 19 VP4N
280567 - ..
280568 - 22. Fatigue, weakness, shortness of
280569 - breath, heavy chest, cough symptoms
280570 - of pulmonary embolism, attributed
280571 - to loss of fitness from low energy
280572 - caused by chemotherapy
280573 - treatments............................ 050729, ref SDS 19 JP9J
280575 - ..
280576 - 23. Chemotherapy Taxotere capecitabine
280577 - (Xeloda) treatment ends prior to
280578 - mastectomy surgery.................... 050916, ref SDS 20 407N
280580 - ..
280581 - 24. Coumadin treatment for pulmonary
280582 - embolism ended........................ 051007, ref SDS 21 RZ4I
280584 - ..
280585 - 25. Mastectomy surgery.................... 051021, ref SDS 22 0001
280587 - ..
280588 - 26. Lymphedema diagnosed.................. 060106, ref SDS 23 MW8J
280590 - ..
280591 - 27. Rising energy after ending chemotherapy
280592 - enabled vigorous exercise to restore
280593 - fitness that strengthens immune system
280594 - to resist cancer recurrence, caused
280595 - lymphedema in left arm to increase
280596 - significantly......................... 060320, ref SDS 24 X95Y
280598 - ..
280599 - 28. Lessons learned exercise to increase
280600 - fitness and strengthen immune system
280601 - to resist cancer, conflicts with
280602 - mastectomy to reduce risks of cancer
280603 - recurrence because very wide
280604 - breast surgery increases
280605 - lymphedema............................ 060428, ref SDS 25 M89K
280607 - ..
280608 - 29. IBC recurrence diagnosed, patient
280609 - begins treatment with Taxotere and
280610 - capecitabine (Xeloda)................. 060721, ref SDS 26 0001
280612 - ..
280613 - 30. Millie increasing fatigue, low energy,
280614 - shortness of breath, falls at
280615 - BART station.......................... 060914, ref SDS 27 ZQ5I
280617 - ..
280618 - 31. Kaiser orders CT test for pulmonary
280619 - embolism; test on 060930 discovers
280620 - pulmonary embolism recurrence;
280621 - patient resumes
280622 - treatment............................. 061002, ref SDS 28 MI5I
280624 - ..
280625 - 32. Enlarged right ventricle heart disorder
280626 - Cor Pulmonale reported in pathology
280627 - findings for CT test on
280628 - 060930................................ 061012, ref SDS 29 7E5L
280630 - ..
280631 - 33. Millie asks when she can return to gym
280632 - to resume exercise in order to regain
280633 - fitness to resist
280634 - cancer................................ 061020, ref SDS 30 VJ4J
280636 - ..
280637 - 34. Pulmonary embolism symptoms increase
280638 - fatigue, shortness of breath weakness,
280639 - Kaiser prescribes procrit
280640 - for anemia............................ 061110, ref SDS 31 CV5L,
280642 - ..
280643 - 35. Patient ends treatment with Taxotere
280644 - and capecitabine; planning to start
280645 - new treatment......................... 061201, ref SDS 32 0001
280647 - ..
280648 - 36. Case study Cellulitis and lymphedema
280649 - indicates risks increase with exercise
280650 - after surgery removes lymph
280651 - nodes................................. 061203, ref SDS 33 YT4M
280653 - ..
280654 - 37. Doctor orders CT test to compare with
280655 - test on 060930 to evaluate whether
280656 - pulmoanry embolism no longer visualized
280657 - as reported on prior diagnosis,
280658 - reported on 041230.................... 061208, ref SDS 34 Q93H
280660 - ..
280661 - 38. Case study Millie requests examination
280662 - heart specialist for heart disorder
280663 - Cor Pulmonale......................... 061228, ref SDS 35 JU9L
280665 - ..
280666 - 39. CT test failed to make comparison
280667 - says nothing about pulmonary embolism;
280668 - doctor advises Millie may have
280669 - permanent lung
280670 - damage................................ 070105, ref SDS 36 XX8H
280672 - ..
280673 - 40. Doctor advised Millie can resume
280674 - exercise and to be
280675 - careful............................... 070105, ref SDS 36 G35K
280677 - ..
280678 - 41. Cellulitis and lymphedema case study
280679 - traces all causation in Millie's
280680 - patient history....................... 070130, ref SDS 37 VX6F
280682 - ..
280683 - 42. Millie exercising in the gym twice
280684 - on consecutive days, 1st time in 6
280685 - months; and following treatment with
280686 - cetuximab on clinical study at
280687 - UCSF on 070201........................ 070204, ref SDS 39 JJ7O
280689 - ..
280690 - 43. Energy increases, shortness of breath,
280691 - fatigue, weakness subside 10 weeks
280692 - after ending treatment for 3rd relapse
280693 - of IBC with Taxotere and cacecitabine;
280694 - Millie is exercising in the gym again,
280695 - playing tennis 2 days 1st time in
280696 - many years, her pulse
280697 - reached 144........................... 070218, ref SDS 0 N05H
280699 - ..
280700 - 44. Healthy medical team at UCSF comments
280701 - how well, fit, and strong Millie looks
280702 - after 2 cycles treatment with cetuximab,
280703 - and higher energy enabling
280704 - regular exercise...................... 070329, ref SDS 42 N49K
280706 - ..
280707 - 45. Healthy primary care physician at Kaiser
280708 - comments how well, fit, and strong Millie
280709 - looks after 2 cycles treatment with
280710 - cetuximab, and higher energy enabling
280711 - regular exercise...................... 070330, ref SDS 43 N49K
280713 - ..
280714 - 46. Millie cannot remember feeling better
280715 - after starting exercise possible
280716 - with cetuximab
280717 - treatments............................ 070418, ref SDS 44 PY6W
280719 - ..
280720 - 47. Cellulitis lymphedema recurrence during
280721 - treatment for cancer at UCSF; evident
280722 - cause increased exercise to stimulate
280723 - bone marrow that produces new blood that
280724 - maintains immune system essential for
280725 - chemotherapy treatments; exercise further
280726 - maintains physicial fitness essential
280727 - for aggressive chemotherapy
280728 - treatments to recover from
280729 - cancer................................ 070607, ref SDS 45 ZH6I
280731 - ..
280732 - 48. Lymphedema and Cellulitis risk declines
280733 - gradually after surgery remove cancerous
280734 - lymph nodes; lymphatic system gradually
280735 - becomes more robust because remaining
280736 - lymph nodes increase capacity so that
280737 - exercise can continue to maintain fitness
280738 - essential for aggressive chemotherapy
280739 - treatment to recover from cancer
280740 - reported by surgeon at
280741 - Kaiser................................ 080606, ref SDS 46 4P7L
280742 -
280743 -
280744 -
280745 -
280746 -
280747 -
280748 -
280749 -
280750 -
2808 -